{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:16:29Z","timestamp":1780647389635,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjcard.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T03:49:38Z","timestamp":1693972178000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Biomarkers as Prognostic Markers for Aortic Stenosis: A Review"],"prefix":"10.1016","volume":"206","author":[{"given":"Ankit","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selia","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baseer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrija","family":"Hajra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.08.001_bib0001","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehy107","article-title":"Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections","volume":"39","author":"Durko","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jcmg.2019.01.036","article-title":"Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement","volume":"13","author":"Lindman","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001040","article-title":"Biological variation of cardiac markers in patients with aortic valve stenosis","volume":"6","author":"Peeters","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/eurheartj\/ehac504","article-title":"Valvular heart disease: shifting the focus to the myocardium","volume":"44","author":"Ajmone Marsan","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0006","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0007","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jcmg.2017.06.018","article-title":"B-type natriuretic peptide and high sensitivity cardiac troponin for risk stratification in low-flow, low-gradient aortic stenosis: a substudy of the TOPAS study","volume":"11","author":"Dahou","year":"2018","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamacardio.2021.5916","article-title":"Association of annual N-terminal pro-brain natriuretic peptide measurements with clinical events in patients with asymptomatic nonsevere aortic stenosis: a post hoc substudy of the SEAS trial","volume":"7","author":"Hadziselimovic","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2582938","article-title":"TAVR: a review of current practices and considerations in low-risk patients","volume":"2020","author":"Spears","year":"2020","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006112","volume":"6","author":"Mizutani","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006570","article-title":"Inflammation and circulating natriuretic peptide levels","volume":"13","author":"Fish-Trotter","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0012","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.3390\/ijms22126212","article-title":"Diabetes mellitus and its implications in aortic stenosis patients","volume":"22","author":"Mourino-Alvarez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0013","first-page":"2433","article-title":"Impact of several proinflammatory and cell degradation factors in patients with aortic valve stenosis","volume":"17","author":"Lurins","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/24748706.2017.1329959","article-title":"Biomarkers in Aortic stenosis: a systematic review","volume":"1","author":"Redfors","year":"2017","journal-title":"Struct Heart"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jjcc.2020.02.019","article-title":"Multi-biomarker mortality prediction in patients with aortic stenosis undergoing valve replacement","volume":"76","author":"Spampinato","year":"2020","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001325","article-title":"Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: a population-based nested case-referent study","volume":"7","author":"Holmgren","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0017","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/eurheartj\/ehu189","article-title":"High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis","volume":"35","author":"Chin","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0018","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.amjcard.2015.08.016","article-title":"Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation","volume":"116","author":"Koskinas","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amjcard.2018.11.030","article-title":"ALICE (All-Literature Investigationof Cardiovascular Evidence) Group. Meta-analysis of impact of baseline N-terminalPro-Brain natriuretic peptide levels on survival after transcatheter aortic valve implantation for aortic stenosis","volume":"123","author":"Takagi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0020","first-page":"29","article-title":"Biomarkers associated with mortality in aortic stenosis: a systematic review and meta-analysis","volume":"9","author":"White","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017574","article-title":"Baseline NT-proBNP accurately predicts symptom response to transcatheter aortic valve implantation","volume":"9","author":"Allen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0022","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1194\/jlr.R051870","article-title":"Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis","volume":"57","author":"Thanassoulis","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0023","first-page":"22543","article-title":"Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression","volume":"8","author":"Olgun K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2020.03.037","article-title":"Additive value of high-density lipoprotein cholesterol and C-reactive protein Level assessment for prediction of 2-year mortality after transcatheter aortic valve implantation","volume":"126","author":"Zieli\u0144ski","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00059-019-4826-3","article-title":"Prognostic value of lipid levels in short-term outcome after TAVI","volume":"45","author":"Yelge\u00e7","year":"2020","journal-title":"Herz"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0026","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00380-019-01448-4","article-title":"Predictive value of preprocedural procalcitonin for short-and long-term mortality after transfemoral transcatheter aortic valve implantation","volume":"34","author":"Keranov","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167072","article-title":"Risk assessment of patients undergoing transfemoral aortic valve implantation upon admission for post-interventional intensive care and surveillance: implications on short- and midterm outcomes","volume":"11","author":"Al-Rashid","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0028","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ehf2.12837","article-title":"Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation","volume":"7","author":"Hoffmann","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.amjcard.2023.08.001_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21470\/1678-9741-2019-0114","article-title":"The Prognostic Value of C-reactive protein to albumin ratio in patients with isolated degenerative aortic valve stenosis undergoing surgical aortic valve replacement","volume":"35","author":"Kahraman","year":"2020","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0030","doi-asserted-by":"crossref","first-page":"e23977","DOI":"10.1002\/jcla.23977","article-title":"Tumor necrosis factor alpha\u2014an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?","volume":"35","author":"Mirna","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0031","first-page":"31","article-title":"Increased serum chemerin level to predict early onset of aortic valve stenosis","volume":"8","author":"Lurins","year":"2018","journal-title":"Biomed Rep"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0032","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/biomedicines9081041","article-title":"Thioredoxin-1 and correlations of the plasma cytokines regarding aortic valve stenosis severity","volume":"9","author":"Tretjakovs","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/medicina57010078","article-title":"Prognostic utility of circulating growth factors in aortic valve stenosis: a pilot study","volume":"57","author":"Hofmanis","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005594","article-title":"GDF-15 (Growth Differentiation Factor 15) is associated with lack of ventricular recovery and mortality after transcatheter aortic valve replacement","volume":"10","author":"Kim","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14017431.2016.1151928","article-title":"Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis","volume":"50","author":"Blyme","year":"2016","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109080","article-title":"The impact of SGLT2 inhibitors on inflammation: a systematic review and meta-analysis of studies in rodents","volume":"111","author":"Theofilis","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0037","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12933-019-0894-1","article-title":"Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant Type 2 diabetes: a retrospective cross-sectional study","volume":"18","author":"Czestkowska","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751214","article-title":"The role of SGLT2 inhibitors in atherosclerosis: a narrative mini-review","volume":"12","author":"Pahud de Mortanges","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0039","unstructured":"ClinicalTrials.com. Dapagliflozin after transcatheter aortic valve implantation (DapaTAVI). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04696185. Accessed on January 12, 2022."},{"key":"10.1016\/j.amjcard.2023.08.001_bib0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0041","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces lipoprotein (a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2021.100062","article-title":"Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis","volume":"11","author":"Lagoutte","year":"2021","journal-title":"Matrix Biol Plus"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0043","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ncrna.2020.02.005","article-title":"Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management? [published correction appears in Noncoding RNA Res 2020;5:219]","volume":"5","author":"Nader","year":"2020","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0044","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012418-012827","article-title":"Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers","volume":"14","author":"Halushka","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.amjcard.2023.08.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002150","article-title":"Circulating microRNA profiling needs further refinement before clinical use in patients with aortic stenosis","volume":"4","author":"Coffey","year":"2015","journal-title":"J Am Heart Assoc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923007373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923007373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:47:46Z","timestamp":1757573266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923007373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"alternative-id":["S0002914923007373"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.001","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers as Prognostic Markers for Aortic Stenosis: A Review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}